FLOWERS KIRSTEN 4
4 · PMV Pharmaceuticals, Inc. · Filed Jun 5, 2026
Research Summary
AI-generated summary of this filing
PMVP Director Kirsten Flowers Receives 42,000-Share Award
What Happened Kirsten Flowers, a director of PMV Pharmaceuticals (PMVP), was granted a derivative award covering 42,000 shares on June 4, 2026. The filing reports an acquisition price of $0.00 (no cash paid) and shows the transaction as an award/grant rather than an open-market purchase or sale.
Key Details
- Transaction date: 2026-06-04; Transaction type: Award/Grant (code A); Price reported: $0.00.
- Shares involved: 42,000 derivative shares granted. Reported total value on the Form 4 is $0 (award/derivative).
- Shares owned after transaction: Not stated in the provided filing.
- Footnote: F1 — the shares/options vest on the earlier of (i) June 4, 2027 or (ii) the date of the issuer's next annual meeting of stockholders.
- Filing timing: Form 4 filed on 2026-06-05 for a 2026-06-04 transaction (appears timely).
Context This is a compensation-related grant to a director (routine for boards) and is recorded as a derivative award that vests in the future per the footnote. Derivative grants typically do not indicate immediate buying or selling of stock; they represent potential future ownership if and when vesting conditions are met.
Insider Transaction Report
Form 4
FLOWERS KIRSTEN
Director
Transactions
- Award
Stock Option (right to buy)
[F1]2026-06-04+42,000→ 42,000 totalExercise: $1.19Exp: 2036-06-04→ Common Stock (42,000 underlying)
Footnotes (1)
- [F1]Shares subject to the option vest on the earlier of (i) June 4, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders.
Signature
/s/ Robert Ticktin, by power of attorney|2026-06-05